For the past few decades, alpha-1 antitrypsin deficiency (AATD) treatment has been mostly limited to enzyme therapy. While this type of therapy is able to treat symptoms of…
For the past few decades, clinical trials related to alpha-1 antitrypsin deficiency (AATD), have focused on getting more replacement therapy on the market. New areas of AATD research focus…
Bruce Given, MD explains how alpha-1 antitrypsin deficiency (AATD) is most often associated with pulmonary disease in adults and liver disease in children. However, as treatment of adults…
New advancements in the field of alpha-1 antitrypsin research hold promise for the treatment and possible reversal of liver disease. Recent advances in the safety and viability of…
Valerie A. Gustave, MD, MPH, attending physician, Gotham Medical Associates, talks about acute pancreatitis, which is currently the leading GI diagnosis that admits people to the hospital. Heavy drinkers…
Valerie A. Gustave, MD, MPH, attending physician, Gotham Medical Associates, describes the symptoms of acute pancreatitis, which include: nausea, vomiting, abdominal pain, and general unease. The prognosis for…
Robert M. Strauss, MD, AGAF, FACG, Gastroenterologist, GI Specialists of Georgia, gives an overview of the characteristics and pathology of Clostridium difficile. He explains that when the population of…
Steven Mento, PhD, Co-Founder, President & CEO, Conatus Pharmaceuticals, addresses the need for a better understanding of the causes of liver disease. Conatus’s latest project, Emricasan, a therapy for…
Steven Mento, PhD, Co-Founder, President & CEO, Conatus Pharmaceuticals, introduces Conatus’s latest project, Emricasan, a therapy for acute catastrophic liver disease. With 2 billion people worldwide with liver…
NEW YORK (Reuters Health) – In patients with potentially resectable colorectal liver metastases, the use of combined PET and CT imaging (PET-CT) identifies those with occult extrahepatic disease…